Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
Objective To investigate negative perceptions about generic medicines and evaluate the
proportions of lay people, doctors and pharmacists who hold these perceptions. Design A …
proportions of lay people, doctors and pharmacists who hold these perceptions. Design A …
[HTML][HTML] What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs
Background Considerable emphasis is presently being placed on usage of generic
medicines by governments focussed on the potential economic benefits associated with …
medicines by governments focussed on the potential economic benefits associated with …
Patients' beliefs toward generic medication in Yemen
AAS Jaber, YM Al-Worafi… - Journal of Generic …, 2022 - journals.sagepub.com
Purpose This study aims to explore patients' knowledge and beliefs toward generic
medicines and identify the factors affecting their beliefs toward them in Yemen. Patients and …
medicines and identify the factors affecting their beliefs toward them in Yemen. Patients and …
Patients' beliefs towards generic medicines in The United Arab Emirates
Objectives Patients play an important role in activating the generic medicine policy as their
acceptance of it reported as an essential factor. Therefore, this study aimed to explore the …
acceptance of it reported as an essential factor. Therefore, this study aimed to explore the …
Knowledge, beliefs and factors affecting the use of generic medicines among patients in Ibb, Yemen: A mixed-method study
YM Al-Worafi, WM Alseragi, KM Alakhali… - Journal of Pharmacy …, 2020 - jppcm.org
Objectives: This study was aimed to explore the knowledge and beliefs of patients in Ibb,
Yemen, regarding generic medicines and identify factors affecting their use of these …
Yemen, regarding generic medicines and identify factors affecting their use of these …
Comparing generic drug markets in Europe and the United States: prices, volumes, and spending
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …
drug markets in Europe and the United States. Regulators should make it easier for generic …
[HTML][HTML] The impact of microfluidics in high-throughput drug-screening applications
P De Stefano, E Bianchi, G Dubini - Biomicrofluidics, 2022 - pubs.aip.org
Drug discovery is an expensive and lengthy process. Among the different phases, drug
discovery and preclinical trials play an important role as only 5–10 of all drugs that begin …
discovery and preclinical trials play an important role as only 5–10 of all drugs that begin …
21st century pharmacovigilance: efforts, roles, and responsibilities
In an era when the number of expedited and conditional review pathways for newly
available brand-name drugs and biosimilar medicines to treat serious and life-threatening …
available brand-name drugs and biosimilar medicines to treat serious and life-threatening …
Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States
WV Padula, RA Larson, SB Dusetzina… - Journal of the …, 2016 - academic.oup.com
Background: We analyzed the cost-effectiveness of treating incident chronic myeloid
leukemia in chronic phase (CML-CP) with generic imatinib when it becomes available in …
leukemia in chronic phase (CML-CP) with generic imatinib when it becomes available in …
[HTML][HTML] Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence
Background The availability of generic topical dermatological drug products is constrained
by the limited methods established to assess topical bioequivalence (BE). A novel …
by the limited methods established to assess topical bioequivalence (BE). A novel …